Here’s a Textbook Criticism of Econometrics Gone Bad

A couple of weeks ago I linked to a study that suggested the anti-overdose drug Nalexone might, on net, actually cause more opioid deaths. I was skeptical because the data seemed to show no real pattern. The authors drew a dashed red line at the point where Nalexone was legalized, and sure enough, it looked like opioid deaths jumped after the new laws were passed. But the line seemed entirely arbitrary.

Now Andrew Gelman has weighed in. He has pretty much the same criticisms I did, but he also has the statistical chops to be taken seriously. However, he also links to Richard Border, who doesn’t say a word but lets the numbers speak for themselves:

This is a textbook criticism of statistics based on too few data points. As Border shows, you can put the cutoff line anywhere and it looks like there’s a big jump in opioid deaths. But that doesn’t mean anything. The error bars are enormous, and the before-and-after “trends” are meaningless.

I’d add that this also shows the value of simply using common sense. If you remove all the lines and the error bars and simply look at the scatterplot, there’s nothing there. That should make you skeptical from the very start. It’s true that occasionally you can tease real results out of data like this, but you’d better be damn sure of what you’re doing and you’d better check it ten different ways. The authors of this study didn’t do that.

YOUR GIFT DOUBLES THROUGH FRIDAY

Right now, every dollar you give goes twice as far—but only until Friday’s midnight deadline. This is the moment to make your support count double.

In a climate where journalists face mounting pressure to back down, stay silent, or soften their reporting, Mother Jones refuses to flinch. We’re pushing back against intimidation and delivering fierce, independent journalism that holds power accountable—no matter who’s trying to silence us.

But here’s the reality: We’re a nonprofit newsroom with zero corporate backing and no financial cushion. We depend entirely on readers like you to fund the investigations that matter most.

Friday’s 2X match deadline is coming soon. We need you on the team right now. Please chip in and double your impact.

YOUR GIFT DOUBLES THROUGH FRIDAY

Right now, every dollar you give goes twice as far—but only until Friday’s midnight deadline. This is the moment to make your support count double.

In a climate where journalists face mounting pressure to back down, stay silent, or soften their reporting, Mother Jones refuses to flinch. We’re pushing back against intimidation and delivering fierce, independent journalism that holds power accountable—no matter who’s trying to silence us.

But here’s the reality: We’re a nonprofit newsroom with zero corporate backing and no financial cushion. We depend entirely on readers like you to fund the investigations that matter most.

Friday’s 2X match deadline is coming soon. We need you on the team right now. Please chip in and double your impact.

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate